nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ADRA1A—Apraclonidine—glaucoma	0.162	0.218	CbGbCtD
Silodosin—ADRA1A—Dipivefrin—glaucoma	0.13	0.174	CbGbCtD
Silodosin—ADRA1D—Clonidine—glaucoma	0.117	0.157	CbGbCtD
Silodosin—ADRA1B—Clonidine—glaucoma	0.0854	0.115	CbGbCtD
Silodosin—ADRA1A—Clonidine—glaucoma	0.0674	0.0904	CbGbCtD
Silodosin—CYP3A4—Pilocarpine—glaucoma	0.0304	0.0408	CbGbCtD
Silodosin—ABCB1—Timolol—glaucoma	0.0292	0.0391	CbGbCtD
Silodosin—ABCB1—Clonidine—glaucoma	0.0248	0.0333	CbGbCtD
Silodosin—CYP3A4—Brinzolamide—glaucoma	0.0239	0.032	CbGbCtD
Silodosin—CYP3A4—Dorzolamide—glaucoma	0.0231	0.031	CbGbCtD
Silodosin—CYP3A4—Methazolamide—glaucoma	0.0206	0.0276	CbGbCtD
Silodosin—CYP3A4—Acetazolamide—glaucoma	0.0164	0.0221	CbGbCtD
Silodosin—CYP3A4—Clonidine—glaucoma	0.0149	0.0199	CbGbCtD
Silodosin—Breast disorder—Betaxolol—glaucoma	0.000665	0.00293	CcSEcCtD
Silodosin—Dry mouth—Bimatoprost—glaucoma	0.000665	0.00293	CcSEcCtD
Silodosin—Nasal congestion—Timolol—glaucoma	0.00066	0.00291	CcSEcCtD
Silodosin—Nervous system disorder—Apraclonidine—glaucoma	0.000659	0.00291	CcSEcCtD
Silodosin—Nasopharyngitis—Betaxolol—glaucoma	0.000658	0.0029	CcSEcCtD
Silodosin—Rash—Metipranolol—glaucoma	0.000653	0.00288	CcSEcCtD
Silodosin—Skin disorder—Apraclonidine—glaucoma	0.000653	0.00288	CcSEcCtD
Silodosin—Dermatitis—Metipranolol—glaucoma	0.000652	0.00288	CcSEcCtD
Silodosin—Asthenia—Levobunolol—glaucoma	0.00065	0.00287	CcSEcCtD
Silodosin—Libido decreased—Timolol—glaucoma	0.000649	0.00286	CcSEcCtD
Silodosin—Headache—Metipranolol—glaucoma	0.000649	0.00286	CcSEcCtD
Silodosin—Pruritus—Levobunolol—glaucoma	0.000641	0.00283	CcSEcCtD
Silodosin—Nervous system disorder—Bimatoprost—glaucoma	0.000639	0.00282	CcSEcCtD
Silodosin—Dizziness—Carteolol—glaucoma	0.000634	0.0028	CcSEcCtD
Silodosin—Syncope—Brimonidine—glaucoma	0.000634	0.0028	CcSEcCtD
Silodosin—Skin disorder—Bimatoprost—glaucoma	0.000633	0.00279	CcSEcCtD
Silodosin—Diarrhoea—Carbachol—glaucoma	0.00063	0.00278	CcSEcCtD
Silodosin—Palpitations—Brimonidine—glaucoma	0.000625	0.00275	CcSEcCtD
Silodosin—Dizziness—Diclofenamide—glaucoma	0.000624	0.00275	CcSEcCtD
Silodosin—Asthenia—Methazolamide—glaucoma	0.000623	0.00275	CcSEcCtD
Silodosin—Loss of consciousness—Brimonidine—glaucoma	0.000621	0.00274	CcSEcCtD
Silodosin—Diarrhoea—Levobunolol—glaucoma	0.00062	0.00273	CcSEcCtD
Silodosin—Nausea—Metipranolol—glaucoma	0.000615	0.00271	CcSEcCtD
Silodosin—Dizziness—Carbachol—glaucoma	0.000609	0.00268	CcSEcCtD
Silodosin—Insomnia—Apraclonidine—glaucoma	0.000608	0.00268	CcSEcCtD
Silodosin—Syncope—Dorzolamide—glaucoma	0.000605	0.00267	CcSEcCtD
Silodosin—Headache—Carteolol—glaucoma	0.000601	0.00265	CcSEcCtD
Silodosin—Dizziness—Levobunolol—glaucoma	0.000599	0.00264	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000598	0.00264	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Timolol—glaucoma	0.000597	0.00263	CcSEcCtD
Silodosin—Palpitations—Dorzolamide—glaucoma	0.000597	0.00263	CcSEcCtD
Silodosin—Pruritus—Latanoprost—glaucoma	0.000595	0.00262	CcSEcCtD
Silodosin—Rash—Diclofenamide—glaucoma	0.000595	0.00262	CcSEcCtD
Silodosin—Diarrhoea—Methazolamide—glaucoma	0.000594	0.00262	CcSEcCtD
Silodosin—Palpitations—Travoprost—glaucoma	0.000594	0.00262	CcSEcCtD
Silodosin—Loss of consciousness—Dorzolamide—glaucoma	0.000593	0.00262	CcSEcCtD
Silodosin—Shock—Acetazolamide—glaucoma	0.000591	0.00261	CcSEcCtD
Silodosin—Headache—Diclofenamide—glaucoma	0.000591	0.0026	CcSEcCtD
Silodosin—Insomnia—Bimatoprost—glaucoma	0.000589	0.0026	CcSEcCtD
Silodosin—Dry mouth—Brimonidine—glaucoma	0.000589	0.0026	CcSEcCtD
Silodosin—Palpitations—Brinzolamide—glaucoma	0.000586	0.00259	CcSEcCtD
Silodosin—Erectile dysfunction—Betaxolol—glaucoma	0.000586	0.00258	CcSEcCtD
Silodosin—Rash—Carbachol—glaucoma	0.00058	0.00256	CcSEcCtD
Silodosin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00058	0.00256	CcSEcCtD
Silodosin—Dermatitis—Carbachol—glaucoma	0.00058	0.00256	CcSEcCtD
Silodosin—Headache—Carbachol—glaucoma	0.000577	0.00254	CcSEcCtD
Silodosin—Syncope—Pilocarpine—glaucoma	0.000572	0.00252	CcSEcCtD
Silodosin—Nausea—Carteolol—glaucoma	0.00057	0.00251	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000568	0.00251	CcSEcCtD
Silodosin—Headache—Levobunolol—glaucoma	0.000568	0.0025	CcSEcCtD
Silodosin—Shock—Brimonidine—glaucoma	0.000568	0.0025	CcSEcCtD
Silodosin—Nervous system disorder—Brimonidine—glaucoma	0.000566	0.00249	CcSEcCtD
Silodosin—Palpitations—Pilocarpine—glaucoma	0.000564	0.00249	CcSEcCtD
Silodosin—Tachycardia—Brimonidine—glaucoma	0.000563	0.00248	CcSEcCtD
Silodosin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000562	0.00248	CcSEcCtD
Silodosin—Dry mouth—Dorzolamide—glaucoma	0.000562	0.00248	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000561	0.00247	CcSEcCtD
Silodosin—Loss of consciousness—Pilocarpine—glaucoma	0.000561	0.00247	CcSEcCtD
Silodosin—Skin disorder—Brimonidine—glaucoma	0.00056	0.00247	CcSEcCtD
Silodosin—Nausea—Diclofenamide—glaucoma	0.00056	0.00247	CcSEcCtD
Silodosin—Dry mouth—Travoprost—glaucoma	0.00056	0.00247	CcSEcCtD
Silodosin—Dizziness—Latanoprost—glaucoma	0.000556	0.00245	CcSEcCtD
Silodosin—Liver function test abnormal—Timolol—glaucoma	0.000555	0.00245	CcSEcCtD
Silodosin—Dry mouth—Brinzolamide—glaucoma	0.000553	0.00244	CcSEcCtD
Silodosin—Gastrointestinal pain—Apraclonidine—glaucoma	0.000549	0.00242	CcSEcCtD
Silodosin—Rash—Methazolamide—glaucoma	0.000547	0.00241	CcSEcCtD
Silodosin—Dermatitis—Methazolamide—glaucoma	0.000547	0.00241	CcSEcCtD
Silodosin—Nausea—Carbachol—glaucoma	0.000547	0.00241	CcSEcCtD
Silodosin—Headache—Methazolamide—glaucoma	0.000544	0.0024	CcSEcCtD
Silodosin—Breast disorder—Timolol—glaucoma	0.000544	0.0024	CcSEcCtD
Silodosin—Cardiac disorder—Clonidine—glaucoma	0.000543	0.00239	CcSEcCtD
Silodosin—Shock—Dorzolamide—glaucoma	0.000542	0.00239	CcSEcCtD
Silodosin—Hypotension—Brimonidine—glaucoma	0.000539	0.00238	CcSEcCtD
Silodosin—Nausea—Levobunolol—glaucoma	0.000538	0.00237	CcSEcCtD
Silodosin—Nervous system disorder—Travoprost—glaucoma	0.000538	0.00237	CcSEcCtD
Silodosin—Nasopharyngitis—Timolol—glaucoma	0.000538	0.00237	CcSEcCtD
Silodosin—Tachycardia—Travoprost—glaucoma	0.000535	0.00236	CcSEcCtD
Silodosin—Skin disorder—Travoprost—glaucoma	0.000533	0.00235	CcSEcCtD
Silodosin—Sinusitis—Betaxolol—glaucoma	0.000532	0.00235	CcSEcCtD
Silodosin—Abdominal pain—Apraclonidine—glaucoma	0.000531	0.00234	CcSEcCtD
Silodosin—Nervous system disorder—Brinzolamide—glaucoma	0.000531	0.00234	CcSEcCtD
Silodosin—Angiopathy—Clonidine—glaucoma	0.000531	0.00234	CcSEcCtD
Silodosin—Rash—Latanoprost—glaucoma	0.00053	0.00234	CcSEcCtD
Silodosin—Dermatitis—Latanoprost—glaucoma	0.000529	0.00233	CcSEcCtD
Silodosin—Tachycardia—Brinzolamide—glaucoma	0.000529	0.00233	CcSEcCtD
Silodosin—Mediastinal disorder—Clonidine—glaucoma	0.000527	0.00233	CcSEcCtD
Silodosin—Headache—Latanoprost—glaucoma	0.000527	0.00232	CcSEcCtD
Silodosin—Skin disorder—Brinzolamide—glaucoma	0.000526	0.00232	CcSEcCtD
Silodosin—Insomnia—Brimonidine—glaucoma	0.000522	0.0023	CcSEcCtD
Silodosin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000519	0.00229	CcSEcCtD
Silodosin—Nausea—Methazolamide—glaucoma	0.000516	0.00227	CcSEcCtD
Silodosin—Hypotension—Dorzolamide—glaucoma	0.000515	0.00227	CcSEcCtD
Silodosin—Mental disorder—Clonidine—glaucoma	0.000513	0.00226	CcSEcCtD
Silodosin—Hypotension—Travoprost—glaucoma	0.000513	0.00226	CcSEcCtD
Silodosin—Shock—Pilocarpine—glaucoma	0.000512	0.00226	CcSEcCtD
Silodosin—Tachycardia—Pilocarpine—glaucoma	0.000508	0.00224	CcSEcCtD
Silodosin—Hypotension—Brinzolamide—glaucoma	0.000506	0.00223	CcSEcCtD
Silodosin—Insomnia—Dorzolamide—glaucoma	0.000498	0.0022	CcSEcCtD
Silodosin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000498	0.0022	CcSEcCtD
Silodosin—Insomnia—Brinzolamide—glaucoma	0.00049	0.00216	CcSEcCtD
Silodosin—Hypotension—Pilocarpine—glaucoma	0.000486	0.00214	CcSEcCtD
Silodosin—Asthenia—Apraclonidine—glaucoma	0.000482	0.00213	CcSEcCtD
Silodosin—Erectile dysfunction—Timolol—glaucoma	0.000479	0.00211	CcSEcCtD
Silodosin—Urticaria—Acetazolamide—glaucoma	0.000477	0.00211	CcSEcCtD
Silodosin—Pruritus—Apraclonidine—glaucoma	0.000475	0.0021	CcSEcCtD
Silodosin—Gastrointestinal disorder—Travoprost—glaucoma	0.000474	0.00209	CcSEcCtD
Silodosin—Cardiac disorder—Betaxolol—glaucoma	0.000473	0.00208	CcSEcCtD
Silodosin—Insomnia—Pilocarpine—glaucoma	0.000471	0.00208	CcSEcCtD
Silodosin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000468	0.00206	CcSEcCtD
Silodosin—Asthenia—Bimatoprost—glaucoma	0.000467	0.00206	CcSEcCtD
Silodosin—Angiopathy—Betaxolol—glaucoma	0.000462	0.00204	CcSEcCtD
Silodosin—Pruritus—Bimatoprost—glaucoma	0.000461	0.00203	CcSEcCtD
Silodosin—Immune system disorder—Betaxolol—glaucoma	0.00046	0.00203	CcSEcCtD
Silodosin—Diarrhoea—Apraclonidine—glaucoma	0.00046	0.00203	CcSEcCtD
Silodosin—Mediastinal disorder—Betaxolol—glaucoma	0.000459	0.00202	CcSEcCtD
Silodosin—Syncope—Clonidine—glaucoma	0.000457	0.00201	CcSEcCtD
Silodosin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000451	0.00199	CcSEcCtD
Silodosin—Palpitations—Clonidine—glaucoma	0.00045	0.00198	CcSEcCtD
Silodosin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000449	0.00198	CcSEcCtD
Silodosin—Gastrointestinal pain—Travoprost—glaucoma	0.000449	0.00198	CcSEcCtD
Silodosin—Loss of consciousness—Clonidine—glaucoma	0.000448	0.00197	CcSEcCtD
Silodosin—Mental disorder—Betaxolol—glaucoma	0.000446	0.00197	CcSEcCtD
Silodosin—Dizziness—Apraclonidine—glaucoma	0.000444	0.00196	CcSEcCtD
Silodosin—Urticaria—Dorzolamide—glaucoma	0.000438	0.00193	CcSEcCtD
Silodosin—Abdominal pain—Dorzolamide—glaucoma	0.000436	0.00192	CcSEcCtD
Silodosin—Sinusitis—Timolol—glaucoma	0.000435	0.00192	CcSEcCtD
Silodosin—Abdominal pain—Travoprost—glaucoma	0.000434	0.00191	CcSEcCtD
Silodosin—Asthenia—Acetazolamide—glaucoma	0.000431	0.0019	CcSEcCtD
Silodosin—Dizziness—Bimatoprost—glaucoma	0.000431	0.0019	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000431	0.0019	CcSEcCtD
Silodosin—Urticaria—Brinzolamide—glaucoma	0.00043	0.0019	CcSEcCtD
Silodosin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000426	0.00188	CcSEcCtD
Silodosin—Dry mouth—Clonidine—glaucoma	0.000424	0.00187	CcSEcCtD
Silodosin—Dermatitis—Apraclonidine—glaucoma	0.000423	0.00187	CcSEcCtD
Silodosin—Headache—Apraclonidine—glaucoma	0.000421	0.00186	CcSEcCtD
Silodosin—Asthenia—Brimonidine—glaucoma	0.000414	0.00183	CcSEcCtD
Silodosin—Abdominal pain—Pilocarpine—glaucoma	0.000412	0.00181	CcSEcCtD
Silodosin—Diarrhoea—Acetazolamide—glaucoma	0.000411	0.00181	CcSEcCtD
Silodosin—Rash—Bimatoprost—glaucoma	0.000411	0.00181	CcSEcCtD
Silodosin—Dermatitis—Bimatoprost—glaucoma	0.00041	0.00181	CcSEcCtD
Silodosin—Shock—Clonidine—glaucoma	0.000409	0.0018	CcSEcCtD
Silodosin—Pruritus—Brimonidine—glaucoma	0.000408	0.0018	CcSEcCtD
Silodosin—Headache—Bimatoprost—glaucoma	0.000408	0.0018	CcSEcCtD
Silodosin—Nervous system disorder—Clonidine—glaucoma	0.000408	0.0018	CcSEcCtD
Silodosin—Tachycardia—Clonidine—glaucoma	0.000406	0.00179	CcSEcCtD
Silodosin—Skin disorder—Clonidine—glaucoma	0.000404	0.00178	CcSEcCtD
Silodosin—Nausea—Apraclonidine—glaucoma	0.000399	0.00176	CcSEcCtD
Silodosin—Syncope—Betaxolol—glaucoma	0.000398	0.00175	CcSEcCtD
Silodosin—Dizziness—Acetazolamide—glaucoma	0.000397	0.00175	CcSEcCtD
Silodosin—Asthenia—Dorzolamide—glaucoma	0.000395	0.00174	CcSEcCtD
Silodosin—Asthenia—Travoprost—glaucoma	0.000394	0.00174	CcSEcCtD
Silodosin—Palpitations—Betaxolol—glaucoma	0.000392	0.00173	CcSEcCtD
Silodosin—Pruritus—Dorzolamide—glaucoma	0.00039	0.00172	CcSEcCtD
Silodosin—Loss of consciousness—Betaxolol—glaucoma	0.00039	0.00172	CcSEcCtD
Silodosin—Asthenia—Brinzolamide—glaucoma	0.000389	0.00171	CcSEcCtD
Silodosin—Hypotension—Clonidine—glaucoma	0.000388	0.00171	CcSEcCtD
Silodosin—Pruritus—Travoprost—glaucoma	0.000388	0.00171	CcSEcCtD
Silodosin—Nausea—Bimatoprost—glaucoma	0.000387	0.00171	CcSEcCtD
Silodosin—Cardiac disorder—Timolol—glaucoma	0.000386	0.0017	CcSEcCtD
Silodosin—Pruritus—Brinzolamide—glaucoma	0.000383	0.00169	CcSEcCtD
Silodosin—Dizziness—Brimonidine—glaucoma	0.000381	0.00168	CcSEcCtD
Silodosin—Angiopathy—Timolol—glaucoma	0.000378	0.00166	CcSEcCtD
Silodosin—Diarrhoea—Dorzolamide—glaucoma	0.000377	0.00166	CcSEcCtD
Silodosin—Headache—Acetazolamide—glaucoma	0.000377	0.00166	CcSEcCtD
Silodosin—Insomnia—Clonidine—glaucoma	0.000376	0.00166	CcSEcCtD
Silodosin—Immune system disorder—Timolol—glaucoma	0.000376	0.00166	CcSEcCtD
Silodosin—Diarrhoea—Travoprost—glaucoma	0.000375	0.00165	CcSEcCtD
Silodosin—Mediastinal disorder—Timolol—glaucoma	0.000375	0.00165	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000375	0.00165	CcSEcCtD
Silodosin—Asthenia—Pilocarpine—glaucoma	0.000373	0.00165	CcSEcCtD
Silodosin—Diarrhoea—Brinzolamide—glaucoma	0.000371	0.00163	CcSEcCtD
Silodosin—Dry mouth—Betaxolol—glaucoma	0.000369	0.00163	CcSEcCtD
Silodosin—Pruritus—Pilocarpine—glaucoma	0.000368	0.00162	CcSEcCtD
Silodosin—Mental disorder—Timolol—glaucoma	0.000365	0.00161	CcSEcCtD
Silodosin—Dizziness—Dorzolamide—glaucoma	0.000364	0.00161	CcSEcCtD
Silodosin—Rash—Brimonidine—glaucoma	0.000364	0.0016	CcSEcCtD
Silodosin—Dermatitis—Brimonidine—glaucoma	0.000363	0.0016	CcSEcCtD
Silodosin—Dizziness—Travoprost—glaucoma	0.000363	0.0016	CcSEcCtD
Silodosin—Headache—Brimonidine—glaucoma	0.000361	0.00159	CcSEcCtD
Silodosin—Gastrointestinal disorder—Clonidine—glaucoma	0.000359	0.00158	CcSEcCtD
Silodosin—Dizziness—Brinzolamide—glaucoma	0.000358	0.00158	CcSEcCtD
Silodosin—Nausea—Acetazolamide—glaucoma	0.000357	0.00157	CcSEcCtD
Silodosin—Diarrhoea—Pilocarpine—glaucoma	0.000356	0.00157	CcSEcCtD
Silodosin—Shock—Betaxolol—glaucoma	0.000356	0.00157	CcSEcCtD
Silodosin—Nervous system disorder—Betaxolol—glaucoma	0.000355	0.00157	CcSEcCtD
Silodosin—Tachycardia—Betaxolol—glaucoma	0.000353	0.00156	CcSEcCtD
Silodosin—Skin disorder—Betaxolol—glaucoma	0.000352	0.00155	CcSEcCtD
Silodosin—Rash—Dorzolamide—glaucoma	0.000347	0.00153	CcSEcCtD
Silodosin—Dermatitis—Dorzolamide—glaucoma	0.000347	0.00153	CcSEcCtD
Silodosin—Rash—Travoprost—glaucoma	0.000346	0.00153	CcSEcCtD
Silodosin—Dermatitis—Travoprost—glaucoma	0.000346	0.00152	CcSEcCtD
Silodosin—Headache—Dorzolamide—glaucoma	0.000345	0.00152	CcSEcCtD
Silodosin—Dizziness—Pilocarpine—glaucoma	0.000344	0.00152	CcSEcCtD
Silodosin—Headache—Travoprost—glaucoma	0.000344	0.00152	CcSEcCtD
Silodosin—Nausea—Brimonidine—glaucoma	0.000343	0.00151	CcSEcCtD
Silodosin—Rash—Brinzolamide—glaucoma	0.000342	0.00151	CcSEcCtD
Silodosin—Dermatitis—Brinzolamide—glaucoma	0.000341	0.0015	CcSEcCtD
Silodosin—Gastrointestinal pain—Clonidine—glaucoma	0.00034	0.0015	CcSEcCtD
Silodosin—Headache—Brinzolamide—glaucoma	0.000339	0.0015	CcSEcCtD
Silodosin—Hypotension—Betaxolol—glaucoma	0.000338	0.00149	CcSEcCtD
Silodosin—Urticaria—Clonidine—glaucoma	0.00033	0.00146	CcSEcCtD
Silodosin—Abdominal pain—Clonidine—glaucoma	0.000329	0.00145	CcSEcCtD
Silodosin—Rash—Pilocarpine—glaucoma	0.000328	0.00145	CcSEcCtD
Silodosin—Dermatitis—Pilocarpine—glaucoma	0.000328	0.00145	CcSEcCtD
Silodosin—Insomnia—Betaxolol—glaucoma	0.000327	0.00144	CcSEcCtD
Silodosin—Nausea—Dorzolamide—glaucoma	0.000327	0.00144	CcSEcCtD
Silodosin—Headache—Pilocarpine—glaucoma	0.000326	0.00144	CcSEcCtD
Silodosin—Nausea—Travoprost—glaucoma	0.000326	0.00144	CcSEcCtD
Silodosin—Syncope—Timolol—glaucoma	0.000325	0.00143	CcSEcCtD
Silodosin—Nausea—Brinzolamide—glaucoma	0.000322	0.00142	CcSEcCtD
Silodosin—Palpitations—Timolol—glaucoma	0.00032	0.00141	CcSEcCtD
Silodosin—Loss of consciousness—Timolol—glaucoma	0.000318	0.0014	CcSEcCtD
Silodosin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000312	0.00138	CcSEcCtD
Silodosin—Nausea—Pilocarpine—glaucoma	0.000309	0.00136	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000306	0.00135	CcSEcCtD
Silodosin—Dry mouth—Timolol—glaucoma	0.000302	0.00133	CcSEcCtD
Silodosin—Asthenia—Clonidine—glaucoma	0.000298	0.00132	CcSEcCtD
Silodosin—Pruritus—Clonidine—glaucoma	0.000294	0.0013	CcSEcCtD
Silodosin—Shock—Timolol—glaucoma	0.000291	0.00128	CcSEcCtD
Silodosin—Nervous system disorder—Timolol—glaucoma	0.00029	0.00128	CcSEcCtD
Silodosin—Urticaria—Betaxolol—glaucoma	0.000288	0.00127	CcSEcCtD
Silodosin—Skin disorder—Timolol—glaucoma	0.000287	0.00127	CcSEcCtD
Silodosin—Diarrhoea—Clonidine—glaucoma	0.000284	0.00125	CcSEcCtD
Silodosin—Hypotension—Timolol—glaucoma	0.000276	0.00122	CcSEcCtD
Silodosin—Dizziness—Clonidine—glaucoma	0.000275	0.00121	CcSEcCtD
Silodosin—Insomnia—Timolol—glaucoma	0.000267	0.00118	CcSEcCtD
Silodosin—Rash—Clonidine—glaucoma	0.000262	0.00116	CcSEcCtD
Silodosin—Dermatitis—Clonidine—glaucoma	0.000262	0.00115	CcSEcCtD
Silodosin—Headache—Clonidine—glaucoma	0.00026	0.00115	CcSEcCtD
Silodosin—Asthenia—Betaxolol—glaucoma	0.00026	0.00115	CcSEcCtD
Silodosin—Pruritus—Betaxolol—glaucoma	0.000256	0.00113	CcSEcCtD
Silodosin—Gastrointestinal disorder—Timolol—glaucoma	0.000255	0.00113	CcSEcCtD
Silodosin—Diarrhoea—Betaxolol—glaucoma	0.000248	0.00109	CcSEcCtD
Silodosin—Nausea—Clonidine—glaucoma	0.000247	0.00109	CcSEcCtD
Silodosin—Gastrointestinal pain—Timolol—glaucoma	0.000242	0.00107	CcSEcCtD
Silodosin—Dizziness—Betaxolol—glaucoma	0.000239	0.00106	CcSEcCtD
Silodosin—Urticaria—Timolol—glaucoma	0.000235	0.00104	CcSEcCtD
Silodosin—Abdominal pain—Timolol—glaucoma	0.000234	0.00103	CcSEcCtD
Silodosin—Rash—Betaxolol—glaucoma	0.000228	0.00101	CcSEcCtD
Silodosin—Dermatitis—Betaxolol—glaucoma	0.000228	0.00101	CcSEcCtD
Silodosin—Headache—Betaxolol—glaucoma	0.000227	0.001	CcSEcCtD
Silodosin—Nausea—Betaxolol—glaucoma	0.000215	0.000948	CcSEcCtD
Silodosin—Asthenia—Timolol—glaucoma	0.000212	0.000935	CcSEcCtD
Silodosin—Pruritus—Timolol—glaucoma	0.000209	0.000922	CcSEcCtD
Silodosin—Diarrhoea—Timolol—glaucoma	0.000202	0.000892	CcSEcCtD
Silodosin—Dizziness—Timolol—glaucoma	0.000196	0.000862	CcSEcCtD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000193	0.00688	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—PTGFR—glaucoma	0.000192	0.00683	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000191	0.00682	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00019	0.00679	CbGpPWpGaD
Silodosin—Rash—Timolol—glaucoma	0.000186	0.000822	CcSEcCtD
Silodosin—Dermatitis—Timolol—glaucoma	0.000186	0.000821	CcSEcCtD
Silodosin—Headache—Timolol—glaucoma	0.000185	0.000817	CcSEcCtD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000185	0.0066	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—GSTT1—glaucoma	0.000182	0.0065	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CA1—glaucoma	0.000181	0.00644	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00018	0.00641	CbGpPWpGaD
Silodosin—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000179	0.00639	CbGpPWpGaD
Silodosin—Nausea—Timolol—glaucoma	0.000176	0.000774	CcSEcCtD
Silodosin—ABCB4—Metabolism—CTSA—glaucoma	0.000175	0.00624	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000172	0.00614	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000171	0.00611	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000167	0.00595	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CA2—glaucoma	0.000165	0.00589	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000164	0.00587	CbGpPWpGaD
Silodosin—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000162	0.00578	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000161	0.00576	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000161	0.00576	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000159	0.00566	CbGpPWpGaD
Silodosin—ADRA1A—Endothelin Pathways—NOS3—glaucoma	0.000155	0.00554	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000148	0.00528	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—OPN4—glaucoma	0.000146	0.00519	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—CYP1B1—glaucoma	0.000145	0.00518	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—CYP1B1—glaucoma	0.000143	0.0051	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000143	0.00509	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000141	0.00503	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—GSTM1—glaucoma	0.000132	0.00472	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—PTGFR—glaucoma	0.000131	0.00467	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NARFL—glaucoma	0.000128	0.00455	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CA5A—glaucoma	0.000128	0.00455	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000127	0.00453	CbGpPWpGaD
Silodosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000122	0.00435	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—OPN4—glaucoma	0.000121	0.00431	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—TXN—glaucoma	0.000116	0.00415	CbGpPWpGaD
Silodosin—UGT2B7—Biological oxidations—GSTM1—glaucoma	0.000116	0.00414	CbGpPWpGaD
Silodosin—UGT2B7—Metapathway biotransformation—GSTM1—glaucoma	0.000114	0.00408	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—MMP2—glaucoma	0.00011	0.00392	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—PTGFR—glaucoma	0.000109	0.00388	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—OPN4—glaucoma	0.000107	0.00383	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000106	0.00379	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000105	0.00375	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	9.66e-05	0.00345	CbGpPWpGaD
Silodosin—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	9.57e-05	0.00341	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	9.41e-05	0.00336	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GSTT1—glaucoma	9.02e-05	0.00322	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—EDN1—glaucoma	8.64e-05	0.00308	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	8.64e-05	0.00308	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—MMP9—glaucoma	8.26e-05	0.00295	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—OPN4—glaucoma	8.22e-05	0.00293	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL1A—glaucoma	8.1e-05	0.00289	CbGpPWpGaD
Silodosin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.74e-05	0.00276	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	7.72e-05	0.00276	CbGpPWpGaD
Silodosin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.64e-05	0.00272	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—OPN4—glaucoma	7.47e-05	0.00266	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PTGFR—glaucoma	7.4e-05	0.00264	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.27e-05	0.0026	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—FAS—glaucoma	7.22e-05	0.00258	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ABCA1—glaucoma	7.19e-05	0.00256	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CYP1B1—glaucoma	7.19e-05	0.00256	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—EDN1—glaucoma	7.17e-05	0.00256	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—C3—glaucoma	7.12e-05	0.00254	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—OPN4—glaucoma	6.83e-05	0.00244	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTGFR—glaucoma	6.72e-05	0.0024	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—SMO—glaucoma	6.61e-05	0.00236	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	6.41e-05	0.00229	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	6.37e-05	0.00227	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LRP12—glaucoma	6.36e-05	0.00227	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	6.3e-05	0.00225	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.27e-05	0.00224	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CA1—glaucoma	6.23e-05	0.00222	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—OPN4—glaucoma	6.2e-05	0.00221	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PTGFR—glaucoma	6.15e-05	0.00219	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.1e-05	0.00218	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	6.06e-05	0.00216	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CTSA—glaucoma	6.04e-05	0.00215	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.83e-05	0.00208	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GSTM1—glaucoma	5.75e-05	0.00205	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.72e-05	0.00204	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CA2—glaucoma	5.7e-05	0.00203	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	5.69e-05	0.00203	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTGFR—glaucoma	5.58e-05	0.00199	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—OPN4—glaucoma	5.51e-05	0.00196	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—SMO—glaucoma	5.48e-05	0.00196	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	5.46e-05	0.00195	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LRP12—glaucoma	5.28e-05	0.00188	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—TP53—glaucoma	5.28e-05	0.00188	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—MTHFR—glaucoma	5.08e-05	0.00181	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5e-05	0.00178	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	4.96e-05	0.00177	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—SMO—glaucoma	4.87e-05	0.00174	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA5A—glaucoma	4.76e-05	0.0017	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NARFL—glaucoma	4.76e-05	0.0017	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.75e-05	0.00169	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—APOE—glaucoma	4.73e-05	0.00169	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LRP12—glaucoma	4.69e-05	0.00167	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—TP53—glaucoma	4.69e-05	0.00167	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CAV1—glaucoma	4.68e-05	0.00167	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.55e-05	0.00162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—OPN4—glaucoma	4.41e-05	0.00157	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—EDN1—glaucoma	4.36e-05	0.00155	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.22e-05	0.0015	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.19e-05	0.0015	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.18e-05	0.00149	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.16e-05	0.00149	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.15e-05	0.00148	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	4.13e-05	0.00147	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HEYL—glaucoma	4.1e-05	0.00146	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TXN—glaucoma	4.02e-05	0.00143	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTGFR—glaucoma	3.97e-05	0.00142	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.89e-05	0.00139	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—C3—glaucoma	3.81e-05	0.00136	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.68e-05	0.00131	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—OPN4—glaucoma	3.66e-05	0.00131	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—EDN1—glaucoma	3.62e-05	0.00129	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.58e-05	0.00128	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.56e-05	0.00127	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—NOS3—glaucoma	3.54e-05	0.00126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HEYL—glaucoma	3.4e-05	0.00121	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—SMO—glaucoma	3.39e-05	0.00121	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.33e-05	0.00119	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTGFR—glaucoma	3.3e-05	0.00118	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.29e-05	0.00117	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—OPN4—glaucoma	3.25e-05	0.00116	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PTGS2—glaucoma	3.24e-05	0.00116	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—EDN1—glaucoma	3.21e-05	0.00115	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—C3—glaucoma	3.16e-05	0.00113	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTT1—glaucoma	3.11e-05	0.00111	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RPTOR—glaucoma	3.11e-05	0.00111	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TNF—glaucoma	3.07e-05	0.00109	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.05e-05	0.00109	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HEYL—glaucoma	3.02e-05	0.00108	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NCK2—glaucoma	3.01e-05	0.00107	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA5A—glaucoma	2.93e-05	0.00105	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NARFL—glaucoma	2.93e-05	0.00105	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.93e-05	0.00104	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.85e-05	0.00102	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—SMO—glaucoma	2.81e-05	0.001	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—C3—glaucoma	2.81e-05	0.001	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.66e-05	0.00095	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.63e-05	0.000937	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RPTOR—glaucoma	2.58e-05	0.00092	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HDAC9—glaucoma	2.56e-05	0.000913	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SMO—glaucoma	2.5e-05	0.000892	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NCK2—glaucoma	2.5e-05	0.000891	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ABCA1—glaucoma	2.48e-05	0.000885	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1B1—glaucoma	2.48e-05	0.000885	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—EDN1—glaucoma	2.46e-05	0.000878	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA1—glaucoma	2.32e-05	0.000829	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RPTOR—glaucoma	2.29e-05	0.000817	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CTSA—glaucoma	2.25e-05	0.000803	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.24e-05	0.0008	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EDN1—glaucoma	2.24e-05	0.000797	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NCK2—glaucoma	2.22e-05	0.000792	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—C3—glaucoma	2.15e-05	0.000767	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA2—glaucoma	2.12e-05	0.000758	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HDAC9—glaucoma	2.12e-05	0.000758	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.12e-05	0.000757	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	2.04e-05	0.000729	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMO—glaucoma	2e-05	0.000715	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTM1—glaucoma	1.98e-05	0.000708	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—C3—glaucoma	1.95e-05	0.000697	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.89e-05	0.000673	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EDN1—glaucoma	1.86e-05	0.000662	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NTRK2—glaucoma	1.83e-05	0.000654	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.81e-05	0.000647	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—C3—glaucoma	1.78e-05	0.000637	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.77e-05	0.00063	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MTHFR—glaucoma	1.75e-05	0.000625	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMO—glaucoma	1.66e-05	0.000593	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.65e-05	0.000588	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—APOE—glaucoma	1.63e-05	0.000582	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—C3—glaucoma	1.62e-05	0.000578	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CAV1—glaucoma	1.62e-05	0.000577	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.59e-05	0.000566	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NGFR—glaucoma	1.57e-05	0.000561	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTRK2—glaucoma	1.52e-05	0.000542	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.51e-05	0.00054	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TXN—glaucoma	1.5e-05	0.000534	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NTRK1—glaucoma	1.49e-05	0.000533	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMO—glaucoma	1.48e-05	0.000527	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—C3—glaucoma	1.44e-05	0.000514	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA1—glaucoma	1.43e-05	0.000511	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CTSA—glaucoma	1.39e-05	0.000495	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	1.38e-05	0.000491	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.35e-05	0.000482	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.33e-05	0.000476	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EDN1—glaucoma	1.32e-05	0.000471	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA2—glaucoma	1.31e-05	0.000467	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NGFR—glaucoma	1.3e-05	0.000465	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTRK1—glaucoma	1.24e-05	0.000442	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NOS3—glaucoma	1.22e-05	0.000436	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NGF—glaucoma	1.21e-05	0.000433	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTT1—glaucoma	1.16e-05	0.000414	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NGFR—glaucoma	1.16e-05	0.000413	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—C3—glaucoma	1.15e-05	0.000412	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	1.14e-05	0.000407	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—glaucoma	1.12e-05	0.000399	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTRK1—glaucoma	1.1e-05	0.000393	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EDN1—glaucoma	1.1e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—glaucoma	1.07e-05	0.000383	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CAV1—glaucoma	1.06e-05	0.00038	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	1.01e-05	0.000362	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FN1—glaucoma	1.01e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NGF—glaucoma	1.01e-05	0.000359	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BAD—glaucoma	1e-05	0.000357	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDN1—glaucoma	9.73e-06	0.000347	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—C3—glaucoma	9.57e-06	0.000342	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1B1—glaucoma	9.25e-06	0.00033	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ABCA1—glaucoma	9.25e-06	0.00033	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TXN—glaucoma	9.22e-06	0.000329	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NGF—glaucoma	8.95e-06	0.000319	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—glaucoma	8.91e-06	0.000318	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CAV1—glaucoma	8.83e-06	0.000315	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—C3—glaucoma	8.5e-06	0.000303	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FN1—glaucoma	8.41e-06	0.0003	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BAD—glaucoma	8.31e-06	0.000296	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—glaucoma	8.05e-06	0.000287	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—glaucoma	7.92e-06	0.000282	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CAV1—glaucoma	7.84e-06	0.00028	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FN1—glaucoma	7.47e-06	0.000266	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—glaucoma	7.39e-06	0.000264	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BAD—glaucoma	7.38e-06	0.000263	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—glaucoma	7.15e-06	0.000255	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	6.97e-06	0.000249	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—glaucoma	6.68e-06	0.000238	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—glaucoma	6.53e-06	0.000233	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—glaucoma	6.45e-06	0.00023	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—glaucoma	6.08e-06	0.000217	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAV1—glaucoma	6.03e-06	0.000215	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—glaucoma	5.93e-06	0.000212	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—glaucoma	5.8e-06	0.000207	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	5.78e-06	0.000206	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1B1—glaucoma	5.7e-06	0.000203	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCA1—glaucoma	5.7e-06	0.000203	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—glaucoma	5.36e-06	0.000191	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	5.14e-06	0.000183	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—glaucoma	4.81e-06	0.000172	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—glaucoma	4.76e-06	0.00017	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—glaucoma	4.56e-06	0.000163	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—glaucoma	4.56e-06	0.000163	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—glaucoma	4.38e-06	0.000156	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	4.27e-06	0.000152	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—glaucoma	4.17e-06	0.000149	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—glaucoma	4.03e-06	0.000144	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—glaucoma	3.75e-06	0.000134	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAV1—glaucoma	3.71e-06	0.000132	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—glaucoma	3.63e-06	0.00013	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—glaucoma	3.23e-06	0.000115	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—glaucoma	2.81e-06	0.0001	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—glaucoma	2.57e-06	9.16e-05	CbGpPWpGaD
